✦ LIBER ✦

Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy

✍ Scribed by Anitha M. Thomas; Anita I. Kapanen; Jennifer I Hare; Euan Ramsay; Katarina Edwards; Göran Karlsson; Marcel B. Bally

Book ID: 113693564
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 813 KB
Volume: 150
Category: Article
ISSN: 0168-3659
DOI: 10.1016/j.jconrel.2010.11.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and distribution of lip

Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration

✍ Moustapha Hassan; Zuzana Hassan; Christina Nilsson; Mohamed Abdel Rehim; Susanne 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 225 KB

Development of a respirable, sustained r

Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles

✍ Cory J. Hitzman; William F. Elmquist; Lee W. Wattenberg; Timothy S. Wiedmann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

The release rate of 5-fluorouracil (5-FU) from liposomes, microspheres, and lipid-coated nanoparticles (LNPs) was determined by microdialysis to investigate their use as a respirable delivery system for adjuvant (postsurgery) therapy of lung cancer. 5-FU was incorporated into liposomes using thin fi